Cargando…

Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure

Detalles Bibliográficos
Autores principales:	Yalta, Kenan, Zorkun, Cafer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Correspondance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902913/ https://www.ncbi.nlm.nih.gov/pubmed/29455780 http://dx.doi.org/10.1016/j.ihj.2017.11.003

Ejemplares similares

Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive?
por: Yalta, Kenan, et al.
Publicado: (2018)

Late coronary ischemıc syndromes assocıated wıth transcatheter aortıc valve ımplantatıon: A revıew of mechanıstıc and clınıcal aspects
por: Yalta, Kenan, et al.
Publicado: (2018)

Neutrophil-to-lymphocyte ratio: A crucial determinant of reverse remodeling in patients with heart failure undergoing transcatheter aortic valve implantation?
por: Yalta, Kenan
Publicado: (2018)

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
por: Villacorta, Humberto, et al.
Publicado: (2016)

Atypical variants of takotsubo cardiomyopathy: mechanistic and clinical implications
por: Yalta, Kenan, et al.
Publicado: (2020)

Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy
por: Khaja, Misbahuddin, et al.
Publicado: (2022)

Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Pareek, Manan, et al.
Publicado: (2021)

Left ventricular remodeling in rheumatoid arthritis patients without clinical heart failure
por: Park, Elizabeth, et al.
Publicado: (2023)

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
por: Crnko, Sandra, et al.
Publicado: (2020)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure
por: Chaanine, Antoine H., et al.
Publicado: (2020)

Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
por: Chaanine, Antoine H., et al.
Publicado: (2021)

Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure
por: De Marco, M, et al.
Publicado: (2013)

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Hippo Pathway Deficiency Reverses Systolic Heart Failure Post-Infarction
por: Leach, John P., et al.
Publicado: (2017)

The soluble ST2 levels in patients with depression and comorbid heart failure
por: Sikora, A., et al.
Publicado: (2022)

Are Soluble ST2 Levels in the Picogram or Nanogram Range in Serum of Healthy Subjects/Disease Patients?
por: Saluja, Rohit
Publicado: (2014)

Point-of-Care Ultrasound for Evaluation of Systolic Heart Function in Outpatient Hemodialysis Units
por: Lohani, Sadichhya, et al.
Publicado: (2021)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Advances in systolic heart failure
por: Yuzefpolskaya, Melana, et al.
Publicado: (2010)

Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction – A multicenter study
por: Bahuleyan, C.G., et al.
Publicado: (2018)

The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19
por: García-Escobar, Artemio, et al.
Publicado: (2021)

Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users
por: Demirkıran, Aykut, et al.
Publicado: (2018)

Soluble ST2 protein in chronic heart failure is independent of traditional factors
por: Wojtczak-Soska, Karolina, et al.
Publicado: (2013)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021)

Kidney Tubular Injury Biomarkers and Secretory Function in Acute Decompensated Heart Failure
por: Kula, Alexander J., et al.
Publicado: (2022)

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
por: Aleksova, Aneta, et al.
Publicado: (2019)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Biomarkers of Myocardial Injury and Remodeling in Heart Failure
por: Ponikowska, Barbara, et al.
Publicado: (2022)

Echocardiographic evaluation of systolic heart failure
por: Lo, Queenie, et al.
Publicado: (2015)

Systolic pulmonary regurgitation affects the outcome of patients with severe systolic heart failure
por: Hsiao, Shih‐Hung, et al.
Publicado: (2021)

Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction
por: Sun, Yuxi, et al.
Publicado: (2023)

NT-pro BNP and plasma-soluble ST2 as promising biomarkers for hypertension, hypertensive heart disease and heart failure in sub-Saharan Africa
por: Anastase, Dzudie, et al.
Publicado: (2017)

Cardiac reverse remodelling and health status in patients with chronic heart failure
por: Wang, Kaiming, et al.
Publicado: (2021)

Red Cell Distribution Width as a Biomarker for Heart Failure: Still Not Ready for Prime-Time
por: Nadar, Sunil K, et al.
Publicado: (2019)

Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
por: Dimitropoulos, Stathis, et al.
Publicado: (2020)

Cardiac resynchronization therapy for patients with chronic systolic heart failure secondary to Chagas cardiomyopathy in the 21(st) century
por: Bestetti, Reinaldo B.
Publicado: (2014)

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma
por: Jain, Tania, et al.
Publicado: (2017)

Modeling Pathologies of Diastolic and Systolic Heart Failure
por: Genet, M., et al.
Publicado: (2015)

Arrhythmias and Electrocardiographic Changes in Systolic Heart Failure
por: Devkota, Ashok, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ojs9sr6m12r4iqqi3l4hn5eis